Immunotherapies for Neurodegenerative Diseases
The current treatments for neurodegenerative diseases are mostly symptomatic without affecting the underlying cause of disease. Emerging evidence supports a potential role for immunotherapy in the management of disease progression. Numerous reports raise the exciting prospect that either the immune...
Main Authors: | Ibrahim Mortada, Raymond Farah, Sanaa Nabha, David M. Ojcius, Youssef Fares, Wassim Y. Almawi, Najwane Said Sadier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.654739/full |
Similar Items
-
Alarmins, inflammasomes and immunity
by: Najwane Saïd-Sadier, et al.
Published: (2012-12-01) -
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
by: Raymond Farah, et al.
Published: (2018-04-01) -
Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.
by: Najwane Saïd-Sadier, et al.
Published: (2010-04-01) -
Neurodegenerative diseases as proteinopathies-driven immune disorders
by: Fausta Ciccocioppo, et al.
Published: (2020-01-01) -
Mechanistic new insights of flavonols on neurodegenerative diseases
by: Muhammad Shoaib Tahir, et al.
Published: (2021-05-01)